Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles

The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research, central nervous system (CNS) disorders remain the world’s leading cause of disability, in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmaceutics
Egile Nagusiak: Vilella, Antonietta, Ruozi, Barbara, Belletti, Daniela, Pederzoli, Francesca, Galliani, Marianna, Semeghini, Valentina, Forni, Flavio, Zoli, Michele, Vandelli, Maria Angela, Tosi, Giovanni
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2015
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491652/
https://ncbi.nlm.nih.gov/pubmed/26102358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics7020074
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak